| Real-life utilization of real-time continuous glucose monitoring: the complete picture. | |
| | |
MedLine Citation:
|
PMID: 21880227 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Background: Very few studies to date have analyzed the reasons why some people do not use real-time continuous glucose monitoring (RT-CGM) continuously, especially given its positive glycemic outcomes, or choose not to wear it at all, even after learning about its benefits. Methods: A questionnaire was designed to assess real-life use of and issues surrounding RT-CGM. Hemoglobin A1c (HbA1c) and duration of sensor use were also obtained from the patients' charts. Results: Fifty-eight subjects with type 1 diabetes (T1DM), average age 15.0 ± 4.8 years, T1DM duration 5.7 ± 3.8 years, HbA1c 8.8 ± 2.1%, 50% with RT-CGM, were included in the analysis. Hemoglobin A1c was lower with increased RT-CGM use. Real-time continuous glucose monitoring was ordered to improve control. Users liked the continuous data. The most disliked part was pain and discomfort. Occasional users described RT-CGM as annoying, a hassle, and interfering with their lives. Reasons for discontinuing RT-CGM included problematic equipment and inaccuracy (64%), intrusion in life (36%), and insurance issues (29%). Twenty-one percent of nonusers reported RT-CGM to be inconvenient or a hassle or just did not want it. Fifty-two percent of subjects continue to use RT-CGM despite reported problems. Conclusion: Real-time continuous glucose monitoring is a beneficial tool for improving glycemic control, and many use it despite reported problems and hassles with current devices. However, this technology has not been wholeheartedly embraced by many individuals with T1DM, especially in youngsters, because of issues mentioned here. Based on the findings of this study, it is hoped that improvements will be made to RT-CGM technology so that more people with diabetes will embrace this beneficial tool. |
| | |
Authors:
|
Neesha Ramchandani; Sandeep Arya; Svetlana Ten; Sonal Bhandari |
Related Documents
:
|
8244187 - Venous placental reactivity to serotonin in normal and preeclamptic gestants. 12193137 - The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth fac... 17255657 - Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in respons... 3116717 - Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes me... 19381857 - Is male fertility associated with type 2 diabetes mellitus? 16479027 - Insulin resistance and metabolic syndrome in elderly women living in nursing homes. |
Publication Detail:
|
Type: Journal Article Date: 2011-07-01 |
Journal Detail:
|
Title: Journal of diabetes science and technology Volume: 5 ISSN: 1932-2968 ISO Abbreviation: J Diabetes Sci Technol Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-09-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101306166 Medline TA: J Diabetes Sci Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 860-70 Citation Subset: IM |
Copyright Information:
|
© 2011 Diabetes Technology Society. |
Affiliation:
|
Department of Pediatric Endocrinology and Diabetes, The Children's Hospital at Montefiore, Bronx, New York. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of a Novel Continuous Glucose Measurement Device in Patients with Diabetes Mellitus acros...
Next Document: Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.